Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sony Tuteja

Showing results (21-30 of 83) with videos related to

Pageof 9
Sort By:
Pharmacotherapy|April 16, 2014
Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemiaSony Tuteja, Danielle Duffy, Richard L Dunbar, et al.
Journal of the American Heart Association|October 30, 2018
Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to NiacinSony Tuteja, Liming Qu, Marijana Vujkovic, et al.
Pharmacogenetics and Genomics|May 6, 2025
Feasibility of pharmacogenetic-guided selection of postoperative analgesics in gynecologic surgery patients: a prospective, randomized, pilot studyGlenda Hoffecker, Lakeisha Mulugeta-Gordon, Victoria Wittner, et al.
Plos One|January 27, 2017
Expression of Calgranulin Genes S100A8, S100A9 and S100A12 Is Modulated by n-3 PUFA during Inflammation in Adipose Tissue and Mononuclear CellsRachana D Shah, Chenyi Xue, Hanrui Zhang, et al.
Pharmacogenomics|November 15, 2024
Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patientsGlenda Hoffecker, Karl Keat, Lakeisha Mulugeta-Gordon, et al.
JAMA Internal Medicine|May 26, 2018
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016Elias J Dayoub, Matthew Seigerman, Sony Tuteja, et al.
Transplantation|January 25, 2003
Improved freedom from rejection after a loading dose of sirolimusRafik El-Sabrout, Veronica Delaney, Fauzia Butt, et al.
Clinical Chemistry|May 29, 2016
Systematic Review of Calcineurin Inhibitor Monitoring and Dosing Strategies in Renal Transplantation: Notice of a New Report Funded by the Agency for Healthcare Research and QualitySony Tuteja, Stacey Uhl, Brian F Leas, et al.
Mayo Clinic Proceedings|February 7, 2021
COVID-19: Understanding Inter-Individual Variability and Implications for Precision MedicineNaveen L Pereira, Ferhaan Ahmad, Mirnela Byku, et al.
Journal of the American Pharmacists Association : Japha|November 9, 2025
Patient and provider perspectives on the implementation of DPYD testing in oncology care clinics in an academic health systemVictoria Wittner, Jasmine Purcell, Mari Cayabyab, et al.
Pageof 9

Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Pharmacotherapy|April 16, 2014
Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemiaSony Tuteja, Danielle Duffy, Richard L Dunbar, et al.
Journal of the American Heart Association|October 30, 2018
Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to NiacinSony Tuteja, Liming Qu, Marijana Vujkovic, et al.
Pharmacogenetics and Genomics|May 6, 2025
Feasibility of pharmacogenetic-guided selection of postoperative analgesics in gynecologic surgery patients: a prospective, randomized, pilot studyGlenda Hoffecker, Lakeisha Mulugeta-Gordon, Victoria Wittner, et al.
Plos One|January 27, 2017
Expression of Calgranulin Genes S100A8, S100A9 and S100A12 Is Modulated by n-3 PUFA during Inflammation in Adipose Tissue and Mononuclear CellsRachana D Shah, Chenyi Xue, Hanrui Zhang, et al.
Pharmacogenomics|November 15, 2024
Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patientsGlenda Hoffecker, Karl Keat, Lakeisha Mulugeta-Gordon, et al.
JAMA Internal Medicine|May 26, 2018
Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016Elias J Dayoub, Matthew Seigerman, Sony Tuteja, et al.
Transplantation|January 25, 2003
Improved freedom from rejection after a loading dose of sirolimusRafik El-Sabrout, Veronica Delaney, Fauzia Butt, et al.
Clinical Chemistry|May 29, 2016
Systematic Review of Calcineurin Inhibitor Monitoring and Dosing Strategies in Renal Transplantation: Notice of a New Report Funded by the Agency for Healthcare Research and QualitySony Tuteja, Stacey Uhl, Brian F Leas, et al.
Mayo Clinic Proceedings|February 7, 2021
COVID-19: Understanding Inter-Individual Variability and Implications for Precision MedicineNaveen L Pereira, Ferhaan Ahmad, Mirnela Byku, et al.
Journal of the American Pharmacists Association : Japha|November 9, 2025
Patient and provider perspectives on the implementation of DPYD testing in oncology care clinics in an academic health systemVictoria Wittner, Jasmine Purcell, Mari Cayabyab, et al.
Pageof 9